28 July 2017, London: Instinctif Partners, the business communications consultancy, congratulates all of the nominees shortlisted as finalists for the OBN Awards 2017.
Congratulations goes to the four clients of Instinctif Partners Life Sciences’ practice across the nine award categories who have been selected as finalists. These are:
Best Start-up Biotech Company
Best Established Biotech Company
Best Contract Research Organisation
Best Implementation of Digital Healthcare
The full list of finalists can be found here and represents a broad cross-section of companies and individuals who have shown innovation and outstanding contribution across the industry in the last twelve months. The winners will be revealed at the 9th annual OBN Awards dinner on 5 October 2017, in Oxford.
This year, Sue Charles, Managing Partner, Life Sciences at Instinctif Partners, forms part of the esteemed panel of judges which will select the winners in each category.
Commenting on the announcement of finalists she said:
“The OBN awards provide an opportunity for the industry to recognise the outstanding efforts of life sciences companies who have made significant progress over the past twelve months. The quality and breadth of the finalists demonstrates the relevance and impact of life sciences here in the UK.”
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences team has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.
For Further Information:
Managing Partner, Life Sciences
+44 (0)20 7457 2020